338 related articles for article (PubMed ID: 14729654)
1. Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest.
Paruthiyil S; Parmar H; Kerekatte V; Cunha GR; Firestone GL; Leitman DC
Cancer Res; 2004 Jan; 64(1):423-8. PubMed ID: 14729654
[TBL] [Abstract][Full Text] [Related]
2. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
3. Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract.
Cvoro A; Paruthiyil S; Jones JO; Tzagarakis-Foster C; Clegg NJ; Tatomer D; Medina RT; Tagliaferri M; Schaufele F; Scanlan TS; Diamond MI; Cohen I; Leitman DC
Endocrinology; 2007 Feb; 148(2):538-47. PubMed ID: 17095596
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.
Ström A; Hartman J; Foster JS; Kietz S; Wimalasena J; Gustafsson JA
Proc Natl Acad Sci U S A; 2004 Feb; 101(6):1566-71. PubMed ID: 14745018
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
Treeck O; Lattrich C; Springwald A; Ortmann O
Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
[TBL] [Abstract][Full Text] [Related]
8. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
Chang EC; Frasor J; Komm B; Katzenellenbogen BS
Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2.
Paruthiyil S; Cvoro A; Tagliaferri M; Cohen I; Shtivelman E; Leitman DC
Breast Cancer Res Treat; 2011 Oct; 129(3):777-84. PubMed ID: 21120602
[TBL] [Abstract][Full Text] [Related]
10. Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.
Jiang C; Guo J; Wang Z; Xiao B; Lee HJ; Lee EO; Kim SH; Lu J
Breast Cancer Res; 2007; 9(6):R77. PubMed ID: 17986353
[TBL] [Abstract][Full Text] [Related]
11. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.
Power KA; Thompson LU
Breast Cancer Res Treat; 2003 Oct; 81(3):209-21. PubMed ID: 14620916
[TBL] [Abstract][Full Text] [Related]
12. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
[TBL] [Abstract][Full Text] [Related]
13. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
[TBL] [Abstract][Full Text] [Related]
14. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
Reddel RR; Sutherland RL
Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
[TBL] [Abstract][Full Text] [Related]
15. Loss of tumourigenicity of stably ERbeta-transfected MCF-7 breast cancer cells.
Behrens D; Gill JH; Fichtner I
Mol Cell Endocrinol; 2007 Aug; 274(1-2):19-29. PubMed ID: 17597290
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells.
Dago DN; Scafoglio C; Rinaldi A; Memoli D; Giurato G; Nassa G; Ravo M; Rizzo F; Tarallo R; Weisz A
BMC Genomics; 2015 May; 16(1):367. PubMed ID: 25956916
[TBL] [Abstract][Full Text] [Related]
17. Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio.
Pons DG; Nadal-Serrano M; Blanquer-Rossello MM; Sastre-Serra J; Oliver J; Roca P
J Cell Biochem; 2014 May; 115(5):949-58. PubMed ID: 24375531
[TBL] [Abstract][Full Text] [Related]
18. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells.
Zhou S; Turgeman G; Harris SE; Leitman DC; Komm BS; Bodine PV; Gazit D
Mol Endocrinol; 2003 Jan; 17(1):56-66. PubMed ID: 12511606
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of estradiol and its analogs on cyclin D1 and CDK4 expression in estrogen receptor positive MCF-7 and estrogen receptor-transfected MCF-10AEwt5 cells.
Hong J; Shah NN; Thomas TJ; Gallo MA; Yurkow EJ; Thomas T
Oncol Rep; 1998; 5(5):1025-33. PubMed ID: 9683804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
